For appointments, please call:
(303) 823-4882
Newer antidepressants are needed for the many individuals with major depressive disorder (MDD) that do not respond adequately to treatment and because of a delay of weeks before the emergence of therapeutic effects. Recent evidence from clinical trials shows that the NMDA antagonist ketamine is a revolutionary novel antidepressant because it acts rapidly and is...
We were honored to be recently featured recently in The Denver Post, at https://www.denverpost.com/2022/12/24/ketamine-infusions-depression-chronic-pain-colorado. It is always beneficial when…
Measures to contain the spread of coronavirus have inadvertently increased teen depression and suicide risk, as demonstrated by Mayne…
A recent study[1] published in the January 5, 2021 American Journal of Psychiatry by Dr. Adriana Feder and her…
Ketamine continues to gain recognition, by both lay public and medical professionals, as a remarkably effective antidepressant, with minimal…
Many of our ketamine therapy patients tell us that the COVID-19 pandemic is causing a dramatic increase in their…